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Abstract
 
Somatic hypermutation and class switch recombination (CSR) contribute to the somatic diver-
sification of antibodies. It has been shown that MutS homologue (Msh)6 (in conjunction with
Msh2) but not Msh3 is involved in generating A/T base substitutions in somatic hypermuta-
tion. However, their roles in CSR have not yet been reported. Here we show that 
 
Msh6
 
 
 
/
 
 
 
mice have a decrease in CSR, whereas 
 
Msh3
 
 
 
/
 
 
 
 mice do not. When switch regions were ana-
lyzed for mutations, deficiency in Msh6 was associated with an increase in transition mutations
at G/C basepairs, mutations at RGYW/WRCY hotspots, and a small increase in the targeting
of G/C bases. In addition, 
 
Msh6
 
 
 
/
 
 
 
 mice exhibited an increase in the targeting of recombination
sites to GAGCT/GGGGT consensus repeats and hotspots in S
 
 
 
3 but not in S
 
 
 
. In contrast to
 
Msh2
 
 
 
/
 
 
 
 mice, deficiency in Msh6 surprisingly did not change the characteristics of S
 
 
 
-S
 
 
 
3
switch junctions. However, 
 
Msh6
 
 
 
/
 
 
 
 mice exhibited a change in the positioning of S
 
 
 
 and
S
 
 
 
3 junctions. Although none of these changes were seen in 
 
Msh3
 
 
 
/
 
 
 
 mice, they had a higher
percentage of large inserts in their switch junctions. Together, our data suggest that MutS
homologues Msh2, Msh3, and Msh6 play overlapping and distinct roles during antibody diver-
sification processes.
Key words: isotype switching • mismatch repair • switching junction • switch region 
mutation • somatic hypermutation
 
Introduction
 
In mammals, the antibody response is diversified by somatic
hypermutation (SHM) and class switch recombination
(CSR) to produce high affinity antibodies of all possible
isotypes (1). SHM introduces point mutations in the vari-
able region that encodes the antigen binding sites at a rate
that is one million times higher than the mutation rate of
other genes. During CSR, the 
 
 
 
 constant region (C
 
 
 
) is
replaced by downstream C
 
 
 
, C
 
 
 
, or C
 
 
 
 genes through
region-specific intrachromosomal recombination between
the 
 
 
 
 switch region (S
 
 
 
) and one of the downstream 
 
 
 
, 
 
 
 
,
or 
 
 
 
 switch regions that are 5
 
 
 
 to these constant region
genes (2). Although SHM is primarily a mutational event
and CSR requires recombination, both are initiated by the
B cell–specific protein, activation-induced cytidine deaminase
(AID) (3–5). AID deaminates dCs on single stranded DNA
to generate dU (6–11). Single stranded DNA is created in
vivo by transcription (6, 10, 11) and WRCY (W 
 
  
 
A or
T, R 
 
  
 
A or G, Y 
 
  
 
C or T) hotspots are preferentially
targeted for mutation (12). The resulting G-U mismatches
may then be replicated to introduce G to A and C to T
transitions or the dU is converted to an abasic site by uracil
DNA glycosylase leading to both transition and transversion
mutations (13, 14). Alternatively, G-U mismatches are rec-
ognized by the mismatch repair (MMR) system, excised,
and replaced by error prone polymerases to produce flank-
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ing mutations primarily at A/T base pairs that are not in
hot spots (15–17). The fact that AID is required for both
SHM and CSR supports the idea that mutations are intro-
duced before CSR (18).
Mice deficient in MutS homologue (Msh)2 or Msh6
have more mutations at G/C bases and more transition mu-
tations at G/C basepairs and in hotspot motifs in SHM (for
review see 19). Similar changes were also observed in mice
with a mutation in the ATPase domain of Msh2 (20). In
contrast, 
 
Msh3
 
 
 
/
 
 
 
 mice do not have a detectable change in
the frequency or characteristics of variable (V) region muta-
tion (21). These findings suggest that the Msh2-Msh6 het-
erodimer that is predominantly involved in the repair of
base–base substitutions and single base insertion/deletions
(22, 23), but not the Msh2-Msh3 heterodimer that is pre-
dominantly involved in the repair of single base insertion/
deletions and larger insertion/deletion mismatches (23),
generates mutations on A/T base pairs during SHM (for re-
view see 19). Mice deficient or mutant in Msh2 have a de-
creased frequency of CSR (20, 24–26), suggesting that
MMR plays a role in CSR and connects the processes of
SHM and CSR (for review see 19). There has been contro-
versy on whether MMR plays a direct role in SHM and
CSR (19, 27). Recent studies have shown that exonuclease
1 (Exo1) (28, 29), which is a part of the MMR process,
plays a role in SHM and CSR and that both Exo1 and
Mlh1 are associated with the V region of cultured B cells
only when they are undergoing SHM (30). Although this
and other recent studies on MMR-deficient mice (31, 32)
indicate a direct role for MMR in CSR and SHM, many
additional proteins such as Ku, DNA-PK
 
cs
 
, 
 
 
 
-H2AX,
53BP1, and ATM, which are required to repair double
stranded DNA breaks, are involved in CSR but not in
SHM (33–38). It is still unclear how these different factors
are coordinated with the changes in the chromatin structure
that make the switch regions accessible for sterile transcrip-
tion, mutation, double stranded break formation, and pro-
cessing and ligation of the DNA ends in CSR (2, 39–42).
When B cells from 
 
Msh2
 
 
 
/
 
 
 
 mice are stimulated to
carry out CSR in short term culture in vitro
 
,
 
 their S
 
 
 
-S
 
 
 
3
switch junctions have shorter microhomologies, more
blunt junctions, and more insertions than cells from wild-
type littermate mice (43). This has led to the suggestion
that Msh2 recruits a complex(es) that converts the single
stranded breaks created by AID in the switch regions (44)
into double stranded breaks which are then processed and
ligated (43). Even though Msh2 and Msh6 function to-
gether as a heterodimer, Msh2-deficient mice die of colon
and other cancers, whereas Msh6-deficient mice predomi-
nantly die of B cell lymphomas (45). Since many B cell
lymphomas arise in the germinal center cells, it is important
to determine whether the role of Msh6 or Msh3 in CSR is
the same as that of Msh2. In addition, it is important to de-
termine whether the role of these proteins in the genera-
tion of switch region mutations in CSR is the same as in
the generation of variable region mutations. To address
these questions, we examined the efficiency of CSR, the
location and spectrum of switch region mutations, and the
location and characteristics of switch junctions in 
 
Msh3
 
 
 
/
 
 
 
and 
 
Msh6
 
 
 
/
 
 
 
 mice. We also examined the characteristics of
V region mutation in 
 
Msh3
 
 
 
/
 
 
 
 and 
 
Msh6
 
 
 
/
 
 
 
 mice to com-
pare the characteristics of the mutations in the V region to
those in the switch junctions.
Our results indicate that, similar to 
 
Msh2
 
 
 
/
 
 
 
 mice, the
frequency of CSR is lower in 
 
Msh6
 
 
 
/
 
 
 
 B cells than in wild-
type B cells, whereas the frequency of CSR in 
 
Msh3
 
 
 
/
 
 
 
 B
cells is the same as the littermate control B cells. These re-
sults are consistent with the idea that the Msh2–Msh6 com-
plex, but not the Msh2-Msh3 complex, is involved in gen-
erating DNA breaks during CSR. Surprisingly, unlike the
findings in 
 
Msh2
 
 
 
/
 
 
 
 mice (43) the S
 
 
 
-S
 
 
 
3 switch junctions
of 
 
Msh6
 
 
 
/
 
 
 
 mice did not reveal any difference from those of
littermate control mice. Even though neither the rate of
CSR nor the length of microhomologies in the S
 
 
 
-S
 
 
 
3
switch junctions was affected by a deficiency in Msh3, there
was a higher percentage of large inserts in the switch junc-
tions in the 
 
Msh3
 
 
 
/
 
 
 
 mice than in their littermate control
mice, consistent with the notion that Msh3 is involved,
probably in conjunction with Msh2, in the processing of
DNA ends before ligation. Comparison of the mutations in
the switch regions to those in the JH2-JH4 segment of the
V region revealed a similar but somewhat different role for
Msh6 in SHM targeted to the V region and to the donor 
 
 
 
and recipient 
 
 
 
 switch regions. These findings suggest that
the MutS homologues Msh2, Msh3, and Msh6 play over-
lapping and distinct roles in both SHM and CSR.
 
Materials and Methods
 
Mice.
 
The Msh3- and Msh6-deficient mice were reported
previously (21, 46, 47). Both mouse lines were backcrossed to
C57BL/6 mice for more than six generations and were housed
in a pathogen-free facility. Homozygous mice were generated
through heterozygous mating. In all experiments, homozygous-
deficient mice were analyzed simultaneously with at least one lit-
termate control mouse. For Msh6 switch junction analyses, mice
that had been backcrossed separately by the Scharff and Edelman
laboratories for 
 
 
 
3 yr were compared and were indistinguishable.
All mouse experiments were approved by the Albert Einstein
Animal Use Committee.
 
In Vitro Switching Assay.
 
4–10-wk-old mice were used to de-
termine the frequency of CSR. For Msh3, two 
 
Msh3
 
 
 
/
 
 
 
, three
 
Msh3
 
 
 
/
 
 
 
 littermate control mice, and five 
 
Msh3
 
 
 
/
 
 
 
 mice were
analyzed as described previously (48). For Msh6, four wild-type,
three heterozygous, and six homozygous 
 
Msh6
 
 
 
/
 
 
 
 mice were an-
alyzed. B cells were obtained from the spleens of naive mice by
RBC lysis and complement-mediated T cell depletion. Cells
were then cultured in RPMI media containing 10% FCS and 50
 
 
 
g/ml LPS (Sigma-Aldrich) or 50 
 
 
 
g/ml LPS and 50 ng/ml rIL-4
(R&D Systems) for 4 d. The stimulated cells were then har-
vested and stained with anti-IgM CY5 (Jackson Immunochemi-
cals) and either anti-IgG1 or anti-IgG3 FITC (BD Biosciences).
Stained cells were then washed with PBS, fixed with 1% parafor-
maldehyde in PBS, and analyzed with a FACSCalibur (Becton
Dickinson). FACS
 
®
 
 analysis was performed using the FlowJo
software package (Treestar). Cells were gated for viability based
on the forward- and side-scatter profiles. The IgG-positive popu- 
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lation was scored according to the gating profile as described pre-
viously (48).
 
Proliferation Assays.
 
2 
 
 
 
 10
 
5
 
 total spleen cells in 200 
 
 
 
l of the
RPMI media were plated as 5-well replicates in a 96-well culture
plate. On day three, the cells were pulsed with 1 
 
 
 
Ci/well of 
 
3
 
H-
thymidine (NEN) for 
 
 
 
16 h before harvesting onto 96-well
printed filtermats (Wallac) and measuring radioactive incorpora-
tion on a Wallac 1450 Microbeta LSC plate counter.
 
Mutation Analysis of the Upstream Region of the Core S
 
 
 
.
 
Ge-
nomic DNA was isolated using the DNAeasy kit (QIAGEN)
from cells stimulated with 50 
 
 
 
g/ml LPS. DNA obtained from in
vitro–stimulated B cells was used to amplify the upstream of the
core S
 
 
 
 region using Pfu-turbo polymerase essentially as de-
scribed (36), with the 5
 
 
 
 primer 5
 
 
 
-AATGGATACCTCAGTG-
GTTTTTAATGGTGGGTTTA-3
 
  and the 3  primer 5 -GCG-
GCCCGGCTCATTCCAGTTCATTACAG-3 .
S -S 3 Switch Junction Analysis. DNA derived from four
Msh6 / , two Msh6 / , and four Msh6 /  mice was used to am-
plify the recombined sequences. For Msh3, two littermate con-
trols and two Msh3 /  mice were used. S -S 3 junctions were
Figure 1. Effect of Msh6 deficiency and Msh3 deficiency on efficient CSR. LPS stimulates IgG3 switching, whereas LPS   IL4 stimulates IgG1
switching. (A) Representative FACS® profile showing the percentage of IgG1 and IgG3-positive cells from Msh6 control and Msh6 /  mice. (B) Repre-
sentative FACS® profiles showing the percentage of IgG1 and IgG3-positive cells from Msh3 control and Msh3 /  mice. (C) Summary of multiple experi-
ments in which IgG3 switching frequency from Msh6 /  mice and Msh3 /  mice is normalized to their respective controls as a percentage. The white
bars represent the relative IgG1 switching in the presence of LPS compared with the respective wild-type IgG3 switching, which is defined as 100%, rep-
resented by the gray bars. (D) Summary of multiple experiments in which IgG1 switching frequency from Msh6 /  mice and Msh3 /  mice is normal-
ized to their respective controls as a percentage. The gray bars represent the relative IgG3 switching, in the presence of LPS   IL4 compared with the
respective wild-type IgG1 switching, which is defined as 100%, represented by the white bars. (E) B cell proliferation results showing Msh3 / , Msh6 / ,
and their respective controls.Distinct Roles of Msh6 and Msh3 in Class Switch Recombination 50
amplified by PCR using Expand Long Template Taq Polymerase
(Roche) essentially as described (43). The primers were  3-H3:
5 -AACAAGCTTGGCTTAACCGAGATGAGCC-3 , and  3-
2: 5 -TACCCTGACCCAGGAGCTGCATAAC-3 . Amplified
PCR products were cloned using the TA cloning kit (Invitro-
gen). Plasmid DNA was prepared using the Millipore 96-well
miniprep kit. T7 primers (Invitrogen) were used to sequence the
PCR inserts. Sequence alignments were constructed by compar-
ing the PCR sequence with S  germline sequence AF446347
and S 3 germline sequence Musighana using Blast2 alignment
(NCBI). The selection of correct alignments was determined by
the percentage of homology to the germline sequence, the length
of homology, and the existence of the primer sequences used to
amplify the junctions. Only unique junctions were tabulated for
the analysis of the recombination sites.
Mutation Analysis of Switched DNA from S  and S 3 Switch Re-
gions. After the switch junctions were determined, mutations in
the recombined DNA segments were scored by comparing them
to the germline sequences of S  or S 3. Only unique mutations
were tabulated in the mutation spectrum analysis.
Somatic Hypermutation Analysis. To analyze V region SHM,
Peyer’s patch PNA high (PNAhi) B cells of 9–15-mo-old mice
were harvested, stained, and FACS® sorted. The JH2 to JH4 re-
gion was then amplified by using Pfu turbo (Stratagene) as
described previously (20). The primers used to amplify JH2-JH4
region were 5  primer, 5 -GGCACCACTCTCACAGTCTC-
CTCAGG-3  and 3  primer, 5 -TGAGACCGAGGCTAGAT-
GCC-3 . PCR products were cloned and sequenced. For Msh3
mice, two 15-mo-old Msh3 wild-type and two homozygous
mice were analyzed. Additionally, 12 mutations from Msh3 con-
Table I. Effect of Msh6 Deficiency on the Characteristics of Sµ-S 3 Switch Junctions from LPS-stimulated B Cells
A. Microhomologies and Insertions and Blunt Junctions in the Switch Junctions from Msh6 / , Msh6 / , and Msh6 /  Micea 
Microhomologies (%) Insertions (%)
Blunt 1–2 ntb 3–4 nt  5 nt 1–4 nt  5 nt Total
Msh6    17 (17) 34 (34) 12 (12) 16 (16) 9 (9) 11 (11) 99 (100)
Msh6    16 (19) 26 (31) 9 (11) 9 (11) 15 (18) 8 (10) 83 (100) 
Msh6   c 9 (18) 13 (25) 5 (10) 12 (23) 6 (12) 6 (12) 51 (100) 
B. GAGCT/GGGGT Consensus Sequence Targeting in the Switch Junctions for Sµ and S 3 Segments from Msh6 / , Msh6 / , and 
Msh6 /  Mice
S  S 3
Yesd (%) No (%) Yesd (%) No (%)
Msh6    66 (67) 33 (33) 19 (19) 80 (81)
Msh6    54 (65) 29 (35) 23 (28) 60 (72)
Msh6    36 (71)e 15 (29)e 26 (51)f 25 (49)f
C. RGYW/WRCY Hotspot Targeting in the Switch Junctions for Sµ and S 3 Segments from Msh6 / , Msh6 / , and Msh6 /  Mice
S  S 3
Yesd (%) No (%) Yesd (%) No (%)
Msh6    77 (78) 22 (22) 64 (65) 35 (35)
Msh6    55 (66) 28 (34) 60 (72) 23 (28)
Msh6    40 (78)e 11 (22)e 41 (80)g 10 (20)g
aData presented in Table S1. Unique switch junctions compiled from four Msh6   , two Msh6   , and four Msh6    littermate control mice.
bnt, nucleotide.
cNo statistically significant difference between Msh6   , Msh6   , and Msh6    mice in any category.
d“Yes” is defined as the junction is within or adjacent to the consensus or hotspot sequence.
eNo statistically significant difference between Msh6   , Msh6   , and Msh6    mice.
fStatistically different between Msh6    and Msh6    mice ( 2 test; P   0.0001). 
gNo statistically significant difference between Msh6    and Msh6    mice ( 2 test; P   0.0710).Li et al. 51
trols and 17 mutations from Msh3 /  mice reported previously
(21) were included in the mutation spectra. For Msh6, one
Msh6 / , one Msh6 / , and one Msh6 /  mouse ( 8-mo-old)
were used. A pair of NP-immunized Msh6 /  and Msh6 /  mice
( 2-mo-old) was also analyzed. Additionally, four mutations
from Msh6 /  and seven mutations from Msh6 /  mice reported
previously (21) were also used to obtain the mutation spectra.
The spectra of mutation were not different when this old data
was not pooled with the new data.
Statistical Analyses. For grouped or categorized microhomol-
ogy, conserved repeat and hotspot data, the  2 test was used. If
there were more than two categories, one was compared with
the pooled data from the rest of the categories to evaluate the dif-
ference between two different genotypes within the same cate-
gory. When, within any category, there was a number less than
five, Fisher’s exact test was used. P   0.05 is considered statisti-
cally significant.
Online Supplemental Material. In Tables S1 and S2, S -S 3
junctions are shown from Msh6 and Msh3 mouse lines, respec-
tively. Table S3 shows the consensus sequence targeting and
hotspot targeting of S -S 3 junctions from Msh3 mouse line.
Table S4 shows the detailed mutation distribution in the recom-
bined switch regions from Msh6 and Msh3 mouse lines. All
supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20040355/DC1.
Results
Msh6 Deficiency Results in Decreased CSR but Msh3 Defi-
ciency Did Not. To address whether Msh3 or Msh6 is in-
volved in efficient CSR, splenic B cells from both mouse
lines were stimulated with LPS or LPS plus IL-4 to induce
switching to IgG3 or IgG1, respectively. In all CSR ex-
periments, a homozygous mouse was always analyzed with
a wild-type or heterozygous littermate mouse. The rela-
tive change in switching efficiency of a homozygous
mouse was normalized to its wild-type or heterozygous
littermate mouse. In both the Msh6 and Msh3 experi-
ments, the relative switching efficiency of homozygous
mice was comparable when normalized to either their
wild-type or heterozygous littermate mice (Fig. 1, A–D).
Therefore, different experiments were pooled and the rel-
ative switching efficiency was displayed as a percentage of
the control littermates. Fig. 1, A and B, shows the repre-
sentative FACS® data for Msh6 /  and Msh3 /  mice and
their littermate controls, respectively. Msh6 /  B cells
treated with LPS had an approximately threefold reduc-
tion in switching to IgG3 compared with those from their
littermate controls (Fig. 1, A and C). When B cells were
stimulated with LPS and IL-4, Msh6 /  B cells had an ap-
proximately twofold reduction in switching to IgG1 com-
pared with the controls (Fig. 1, A and D). As shown in
Fig. 1, B–D, Msh3 /  mice did not exhibit any defect in
switching to either IgG3 or IgG1. Neither Msh3 nor
Msh6 deficiency affected B cell proliferation during cyto-
kine stimulation (Fig. 1 E). The extent of the defect in
CSR from Msh6-deficient mice is similar to that found in
Msh2-deficient mice (20, 24, 26, 31), suggesting that the
Msh2-Msh6 heterodimer is involved in efficient CSR, as
it is in SHM.
Msh6 Deficiency Does Not Change the S -S 3 Junctions but
Does Change the Targeting of Recombination Sites to the Con-
sensus Repeat and Hotspots in the S 3 Region. In addition
to a decrease in the frequency of switching, Msh2 deficiency
is associated with increased frequencies of blunt junctions
and shorter microhomologies (43). Since Msh2 and Msh6
both caused a decrease in the frequency of switching and
function as a heterodimer in MMR (22), we examined the
S -S 3 junctions from splenic B cells stimulated with LPS
from Msh6 /  mice and their littermate controls. 99 unique
junctions were analyzed from four Msh6 /  mice, 83 unique
junctions from two Msh6 /  mice, and 51 unique junctions
from four Msh6 /  mice. The alignments of these switch
junctions are shown in Table S1, available at http://
www.jem.org/cgi/content/full/jem.20040355/DC1. The
data were categorized and summarized in Table I A. In con-
trast to Msh2 /  mice, there was no increase in blunt junc-
tions and shorter microhomologies in the switch junctions
from Msh6-deficient mice compared with their littermate
controls. However, Msh6 / , Msh6 / , and Msh6 /  mice
all had large inserts in their switch junctions (see Discussion).
Since there is an increased targeting of SHM to hotspots
in the V region in Msh6 /  mice (reference 21 and see Ta-
ble IV), we analyzed the usage of the GAGCT/GGGGT
consensus repeat sequence and RGYW/WRCY hotspots in
the recombination junctions identified. In general, there was
more targeting to the consensus repeats in S  than in S 3
of the recombined switch regions (Table I B). This is prob-
ably due to the fact that there are more such consensus mo-
tifs in the S  than in the S 3 region. However, in Msh6 / 
mice there was an increase in targeting to the consensus re-
peat (Table I B, right) in the S 3 region (51%) compared
with  Msh6 /  mice (19%), whereas the Msh6 /  mice
showed an intermediate frequency (28%). This type of tar-
geting change was not observed in the S  region (Table I
B, left). Similarly, an increased targeting to RGYW/WRCY
hotspots was observed in the S 3 region from Msh6 / 
mice compared with Msh6 /  mice (Table I C, right), al-
though the p-value is 0.0710. Increased use of hotspots was
not observed in S  region (Table I C, left).
Table II. Effect of Msh3 Deficiency on the Characteristics of Sµ-S 3 
Switch Junctions from LPS-stimulated B Cellsa
Microhomologies (%) Insertions (%)
Blunt 1–2 ntb 3–4 nt  5 nt 1–4 nt  5 ntc Total
Controls 6 (14) 20 (46) 5 (12) 10 (23) 2 (5) 0 (0) 43 (100)
Msh3   d 5 (10) 19 (38) 6 (12) 9 (18) 5 (10) 6 (12) 50 (100)
aData presented in Table S2. Unique switch junctions compiled from
two Msh3    mice and two littermate controls.
bnt, nucleotide.
c,dInsert lengths  5 nt from Msh3    mice are statistically different
compared to the controls (P   0.05), whereas microhomology lengths
are not.Distinct Roles of Msh6 and Msh3 in Class Switch Recombination 52
Msh3 Deficiency Does Not Change the Pattern of Micro-
homologies but Does Change the Pattern of Inserts in the S -
S 3 Junctions. Studies in yeast have established that Msh2,
Msh3, Rad1, and Rad10 are involved in removing the non-
homologous DNA end sequences during double stranded
break repair (49). Msh2 and Msh3 could function in a simi-
lar fashion in CSR. Although Msh3 deficiency has no effect
on the frequency of switching, Msh3 might play a role in
the late steps in CSR. Therefore, we examined the S -S 3
junctions from splenic B cells from Msh3-deficient mice
stimulated with LPS. 43 unique junctions were obtained
from the control mice, and 50 unique junctions were ob-
tained from Msh3 /  mice. The complete alignments were
shown in the Table S2, available at http://www.jem.org/
cgi/content/full/jem.20040355/DC1. The data were cate-
gorized and are shown in Table II. There was no difference
in the size distribution of the microhomologies in the junc-
tions from the Msh3 /  and control mice. However, the
Msh3-deficient mice had more large inserts (  5 nt) than
their littermate controls (Fisher’s Exact test, P     0.05).
Therefore, Msh3 deficiency shares the increased occurrence
of large inserts with Msh2-deficiency, even though Msh3 / 
and Msh2 /  mice differ in the frequency of blunt junctions
and in the size of the microhomologies in switch junctions.
Msh3 /  mice and their littermate controls did not differ in
the targeting of recombination to the GAGCT/GGGGT
consensus repeats or hotspots in S  or S 3 (Table S3, A
and B, available at http://www.jem.org/cgi/content/full/
jem.20040355/DC1). Together, these results suggest that
Msh3 is neither involved in the generation of DNA breaks
nor in the initial resolution of breaks, but it could be in-
volved in processing the DNA ends before ligation occurs.
Msh6 Deficiency but not Msh3 Deficiency Changes the Posi-
tioning of Junctions in the Switch Regions. Further analyses of
switch junctions from the Msh3 and Msh6 mouse lines re-
vealed that Msh6 deficiency was associated with a change of
positioning of junctions in the switch regions. Fig. 2 A shows
that Msh6 deficiency significantly increased the usage of 451–
720-bp segment ( 2 test, P   0.0006) (the whole S  core is
760 bp) but did not change the targeting of recombination to
the S  segments 1–150 bp or 151–300 bp. There also ap-
pears to be a decrease in the usage of segment 301–450 bp
( 2 test, P   0.11) (Fig. 2 A). In both 301–450-bp and 451–
720-bp S  segments, Msh6 /  mice showed an intermediate
phenotype (Fig. 2 A). In the S 3 region, deficiency of Msh6
significantly decreased the usage of segment 2,201–2,400 bp
( 2 test, P   0.0354) (the whole S 3 is 2,705 bp), and there
appeared to be an increase in the usage of segment   2,000
bp ( 2 test, P   0.2) (Fig. 2 B). In parallel, we also analyzed
the effect of Msh3 deficiency in the usage of different switch
segments. Fig. 2 C shows the usage of different portions of
S  was not significantly different between the control and
Msh3 /  mice in four different segments. Similar results were
also observed in the S 3 region (Fig. 2 D).
Figure 2. Effect of Msh6 deficiency and Msh3 deficiency on the posi-
tioning of junctions in S  and S 3 regions in S -S 3 switch junctions.
The core S  (GenBank/EMBL/DDBJ accession no. AF446347.1) region
was arbitrarily divided into four different segments: nucleotide 1–150,
151–300, 301–450, and 451–760. The S 3 region (GenBank/EMBL/
DDBJ accession no. M12182) was arbitrarily divided into four different
segments: nucleotide  2000, 2001–2200, 2201–2400, and 2401–2600. Y
axis stands for the percentage of junctions falling into different segments
of switch regions. (A) Summary of junctions falling into different S  seg-
ments from Msh6 / ,  Msh6 / , and Msh6 /   mice. (B) Summary of
junctions falling into different S 3 segments from Msh6 / , Msh6 / ,
and Msh6 /  mice. (C) Summary of junctions falling into different S 
segments from littermate control and Msh3 /  mice. (D) Summary of
junctions falling into different S 3 segments from littermate control and
Msh3 /  mice.Li et al. 53
sequences. The frequency of mutations in Msh6    and
Msh6    littermate mice was 2.8   10 –4 and 2.9   10 4,
respectively, so the data was pooled. As shown in Fig. 3,
the mutation frequency for the control (i.e., Msh6 /  and
Msh6 /  mice) and Msh6 /  mice was 2.9   10 4 and 3.4  
10 4, respectively. Although the frequency of mutation
in the Msh3 /  and control littermates was higher, the dif-
ference in the frequency of mutation between the Msh6-
and Msh3-deficient mice and their respective controls was
not statistically significant. These results indicate that both
Neither Msh3 nor Msh6 Is Required to Generate Muta-
tions in the Upstream of the Core S  Region. To deter-
mine whether Msh3 or Msh6 is required for the generation
of mutations in the switch regions, we first amplified and
sequenced a 561-bp DNA fragment upstream of the core
S  from genomic DNA isolated from stimulated splenic
B cells (36). The region sequenced corresponds to posi-
tion 4600–5160 in the S  germline sequence (GenBank/
EMBL/DDBJ accession no. J0040). Of note, the mutations
seen could be from both recombined and unrecombined
Table III. Effect of Msh6 Deficiency and Msh3 Deficiency on the Characteristics of Switch Region Mutations from LPS-stimulated B Cells 
A. Sµ Region from Msh6 / , Msh6 / , and Msh6 /  Mice
Msh6 /  Msh6 /  Msh6 / 
Mutation frequency ( 10 3) 12.9 7.1 11.3
GC mutations/total 184/278 (66%) 101/148 (68%) 161/211 (76%)a
Tsb mutations at GC/total 94/184 (51%) 54/101 (53%) 128/161 (80%)c
Hotspot mutations/total 92/278 (33%) 71/148 (48%)d 142/211 (67%)e
B. S 3 Region from Msh6 / , Msh6 / , and Msh6 /  Mice
Msh6 /  Msh6 /  Msh6 / 
Mutation frequency ( 10 3) 5.8 4.3 5.7
GC mutations/total 96/161 (60%) 64/101 (63%) 64/87 (74%)f
Tsb mutations at GC/total 61/96 (64%) 40/64 (62%) 53/64 (83%)g
Hotspot mutations/total 29/161 (18%) 39/101 (39%)h 37/87 (42%)h
C. Sµ Region from Littermate Control and Msh3 /  Mice
Control Msh3 / i
Mutation frequency ( 10 3) 12.7 14.7
GC mutations/total 88/127 (69%) 80/128 (63%)
Tsb mutations at GC/total 48/88 (55%) 35/80 (44%)
Hotspot mutations/total 49/127 (38%) 35/128 (27%)
D. S 3 Region from Littermate Control and Msh3 /  Mice
Control Msh3 / j
Mutation frequency ( 10 3) 2.9 6.3
GC mutations/total 19/37 (51%) 46/87 (53%)
Tsb mutations at GC/total 15/19 (79%) 33/46 (72%)
Hotspot mutations/total 9/37 (24%) 21/87 (24%)
aStatistically significant difference between Msh6    or Msh6    and Msh6    mice ( 2 test; aP   0.0198).
bTs, transition.
c,d,e,f,g,hStatistically significant difference between Msh6    or Msh6    and Msh6    mice ( 2 test; cP   0.0001, dP   0.0037, eP   0.0001, fP  
0.0404, gP   0.0139, hP   0.0001).
i,jNo statistical difference between Msh3    and control mice.Distinct Roles of Msh6 and Msh3 in Class Switch Recombination 54
Msh6 and Msh3 are dispensable for generating mutations
upstream of   switch region.
Msh6 Deficiency but not Msh3 Deficiency Increases the Tran-
sition Mutations at G/C and Mutations at Hotspots in Switched
DNA Sequences. To further characterize the mutations
generated in switch regions, we analyzed mutations in rear-
ranged S  and S 3 regions. As shown in Table III A, the
mutation frequency in the S  region of Msh6 /  mice was
similar to that of Msh6 /  mice, whereas Msh6 /  mice
had a lower frequency of mutation than Msh6 /  and
Msh6 /  mice ( 2 test, P   0.0001). The mutation fre-
quency was lower in S 3 region than in S  and Msh6 / 
Figure 3. Effect of Msh6 defi-
ciency and Msh3 deficiency on
the mutation frequency of the
upstream S  region from LPS-
stimulated B cells. Msh3 /  mice
and  Msh6 /  mice were com-
pared with their own littermate
controls. Pie charts were used to
depict the distribution of muta-
tion frequencies and the propor-
tion of sequences with different
number of mutations (numbers
of mutations outside the pie slices).
Table IV. Somatic Hypermutation of the JH2-JH4 Region from Peyer’s Patch B Cells
A.  Msh3 control  Msh6 control
 A G C T Total   A G C T Total
A / 16 5 12 33 A / 9 5 5 19
G 9 / 4 1 14 G 10 / 3 3 16
C 0 2 / 7 9 C 3 2 / 12 17
T4 3 5 / 1 2 T 4 3 6 / 1 3
68 65
Msh3    Msh6   
 A G C T Total  A G C T Total
A / 35 13 20 68 A / 0 1 1 2
G 19 / 4 6 29 G 10 / 2 2 14
C3 7 / 9 1 9 C 2 1 / 2 2 2 5
T 1 41 01 9 / 4 3 T 2 00 / 2
 159           43
B. Controls Msh6    Msh3   
GC mutations/total 56/133 (42%) 39/43 (91%)a 48/159 (30%)c
Tsb mutations at GC/total 38/56 (68%) 32/39 (82%)d 28/48 (58%)e
Hotspot mutations/total 25/133 (11%) 15/43 (35%)f 23/159 (14%)g
a,fStatistically significant difference between Msh6    and control mice ( 2 test; aP   0.0001, fP   0.0478).
bTs, transition.
cStatistically significant difference between Msh3    and control mice ( 2 test; fP   0.0218).
dNo statistically significant difference between Msh6    and control mice.
e,gNo statistically significant difference between Msh3    and control mice.Li et al. 55
mice also had a lower frequency of mutation than Msh6 / 
and Msh6 /  mice (Table III B). The characteristics of the
individual base changes in recombined S  and S 3 regions
from Msh6 / , Msh6 / , and Msh6 /  mice are tabulated in
Table S4 A, available at http://www.jem.org/cgi/content/
full/jem.20040355/DC1. To compare the mutations in the
switch regions to those in the V region in the same mouse
colonies at the same time, we analyzed the characteristics of
SHM in the JH2-JH4 region from both Msh3- and Msh6-
deficient mice.
Msh6-deficient mice had a statistically significant increase
in the percentage of mutations at G/C basepairs in both re-
arranged S  and S 3 regions compared with Msh6 /  mice
( 2 test, P   0.05), whereas Msh6 /  and Msh6 /  mice did
not differ (Table III, A and B). This small but statistically
significant increase in mutations at G/C basepairs in the
switch regions of Msh6 /  mice is less dramatic than the in-
crease in targeting to G/C basepairs seen in the V region
previously (21) and in JH2-JH4 region in the Msh6 /  mice
used in this study (42% for the control versus 91% for
Msh6 /  mice; Table IV, A and B) ( 2 test, P   0.0001).
Msh6 deficiency also increased the percentage of transition
mutations at G/C basepairs in both the S  and S 3 switch
regions (S  region, 51% for Msh6 / , 55% for Msh6 / ,
and 80% for Msh6 /  mice; S 3 region, 64% for Msh6 / ,
62% for Msh6 / , and 83% for Msh6 /  mice [Table III, A
and B]). The extent of this increase in the S  region is
greater than in the V region (Table IV B), whereas it is sim-
ilar in the S 3 region (Table IV B). In addition, Msh6 defi-
ciency increased the percentage of hotspot mutations in the
S  region (33% for Msh6 /  and 67% for Msh6 /  mice)
(Table III A) and in the S 3 region (18% for Msh6 /  and
42% for Msh6 /  mice) (Table III B). This is consistent
with the hotspot mutations in the JH2-JH4 region observed
in  Msh6 /   mice (11% for the control versus 35% for
Msh6 /  mice) (Table IV B). Of note, Msh6 /  mice also
exhibited an increase in the percentage of hotspot mutations
in the recombined S  and S 3 regions compared with
Msh6 /  mice (Table III, A and B).
We performed similar analyses for Msh3 /  mice and
their littermate controls. The characteristics of the individ-
ual base changes in recombined S  and S 3 regions from
the control and Msh3 /  mice are tabulated in Table S4 B.
In the S  region, the mutation frequency was 12.7   10 3
for the control mice and 14.7   10 3 for the Msh3 / 
mice (Table III C). In the S 3 region, the mutation fre-
quency was 2.9   10 3 for the controls and 6.3   10 3 for
the Msh3 /  mice (Table III D). The lower rate of muta-
tion in S 3 than in S  is similar to findings in the Msh6 / 
mice. We had reported previously (21) that Msh3 defi-
ciency did not significantly change the frequency or the
characteristics of the mutations in the V region. When we
examined a larger number of mutations in this study, we
found that there was a small but statistically significant de-
crease in mutation at G/C basepairs (30% compared with
42% [Table IV B]) ( 2 test, P   0.05). There appeared to
be a decrease in transitions (58% compared with 68%) in
the JH2-JH4 regions of the Msh3 /  mice (Table IV B).
Similar small differences were observed in the characteris-
tics of the mutations in the recombined S  region of the
Msh3 /  mice when they were compared with their litter-
mate controls. The transition mutation at G/C was 55% for
the control mice compared with 44% of Msh3 /  mice
(Table III C). The percentage of hotspot mutations was
38% in the control mice compared with 27% in Msh3 / 
mice (Table III C). However, these differences were not
observed in recombined S 3 region (Table III D).
Discussion
MMR plays an important role in maintaining the stabil-
ity of the genome by correcting mismatched bases that arise
during replication and recombination. In addition, when
there is excessive DNA damage the MMR complex signals
for the cell cycle arrest and apoptosis (22). MMR also
prevents homeologous recombination in yeast between
slightly divergent DNA sequences (50). The initial recog-
nition of mismatched bases is performed by Msh2 in associ-
ation with either Msh6 or Msh3 (45). The Msh2-Msh6
heterodimer recognizes single base mismatches and sin-
gle-base insertions/deletions, whereas the Msh2-Msh3 het-
erodimer recognizes single-base insertions/deletions and
larger mismatches (23, 45). Once a mismatch is identified,
the Msh2-Msh6 or Msh2-Msh3 heterodimer recruits addi-
tional proteins in an ATP-dependent manner including the
Mlh1-Pms2 heterodimer, Exo1, PCNA, and potentially
other as yet unidentified factors to complete the process of
mismatch repair (45). Since AID-induced mutations are re-
quired to trigger both SHM and CSR and result in G-U or
G-abasic site mismatches, it is not surprising that Msh2,
Msh6, Exo1, Mlh1, and Pms2 are involved in both of these
processes. Deficiency in any of these proteins results in a
reduced frequency of CSR. Interestingly, the switch junc-
tions found in Msh2 /  and those in Mlh1 /  or Pms2 / 
mice differ (43, 51), suggesting that the function of Msh2 is
different at certain stages of CSR from that of Mlh1 or
Pms2. This is consistent with the fact that Msh2 /  or
Msh6 /  mice and Mlh1 /  or Pms2 /  mice have differ-
ent mutation spectra in SHM (for review see 19). It has
been hypothesized that the Msh2-Msh6 complex affects
CSR and SHM by participating in the repair of AID-gen-
erated mismatches (1, 19, 52). In addition, MMR proteins
especially Msh3 could also play a role in CSR by process-
ing the nonhomologous ends created by staggered DNA
breaks (53) or other recombination structures that might
form in the course of CSR. Since the switch regions con-
tain many nonidentical repeats, large mismatches could be
created during recombination that would require the par-
ticipation of the Msh2-Msh3 heterodimer. Therefore, it is
important to determine the precise role of Msh6 or Msh3
relative to Msh2 in CSR.
In this study, we have shown that Msh6 /  mice exhibit
a decrease in the frequency of CSR, whereas Msh3 /  mice
do not, suggesting that Msh6 is needed for efficient CSR,Distinct Roles of Msh6 and Msh3 in Class Switch Recombination 56
whereas Msh3 is dispensable. It is notable that the extent of
reduction in CSR observed in Msh6 /  mice is similar to
what has been reported in Msh2 /  mice (20, 24, 26, 31),
supporting the idea that Msh2 and Msh6 function together
in CSR. Therefore, one might have expected that Msh6 / 
and  Msh2 /  mice would have had a similar pattern of
switch junctions. However, after analyzing a large number
of unique recombination sites from Msh6 / , Msh6 / , and
Msh6 /  mice, we were surprised to find that the frequency
of blunt junctions and the distribution of various sizes of mi-
crohomologies and inserts observed from Msh6 /  mice did
not differ from littermate Msh6 /  or Msh6 /  mice. This is
in contrast to the phenotype of Msh2 /  mice, which have
more blunt junctions, more inserts, and shorter micro-
homologies than wild-type mice in their switch junctions
(43). The switch junction phenotype difference between
Msh6 /  mice and Msh2 /  mice reveals that the loss of
Msh2 and Msh6 has a different impact on CSR and suggests
that they have different roles at certain stages of CSR.
Msh6 /  littermate mice did have some large inserts in their
switch junctions which are not frequently found in wild-
type littermate mice. We think that this is not due to ge-
netic background because these mice are backcrossed to
C57BL/6 for more than six generations. In addition, we do
not believe that this is due to our analysis methods because
the  Msh3 /  mice that were analyzed in parallel with
Msh6 /  mice do not show such inserts and resemble the
wild-type littermate mice published previously (20, 30, 31,
38, 43). In addition, we also found these inserts in Msh6 / 
mice derived from a colony that was backcrossed to C57/
B6 independently for  3 yr (see Materials and Methods).
Although this could be due to the relatively large number of
recombination sites examined in the study, the precise rea-
sons for the large insertions in the control mice remain un-
explained. This could be due to some unknown epigenetic
effects, given that we used heterozygous Msh6 parents to
generate the wild-type littermates.
Although the characteristics of the junctions in Msh6 / 
mice did not differ from those of littermate controls, defi-
ciency in Msh6 did result in other differences in the re-
combination process. The loss of Msh6 was associated with
an increase in the targeting of the recombination sites
to GAGCT/GGGGT consensus repeats and to RGYW/
WRCY hotspots in the S 3 regions but not in the S  re-
gions. These results suggest that in the S 3 region, but not
in the S  region, the generation and/or resolution of DNA
breaks in CSR outside of these sequences is dependent on
Msh6. Our data obtained from Msh6 /  mice suggest that
Msh2 and Msh6 can have different roles in targeting re-
combination to consensus sequences. Indeed, the increase
targeting of the consensus repeats in S  has been observed
in Msh2 /  mice (25). Moreover, mice deficient in both
Msh2 and the consensus sequence in the S  region showed
a synergistic defect in CSR (26), suggesting that the gener-
ation or/and resolution of DNA breaks in CSR outside of
consensus sequences is dependent on Msh2 in the S  re-
gion (26). Interestingly, the difference observed in Msh2 / 
and Msh6 /  mice in the recombination sites is consis-
tent with other functional differences between Msh2 and
Msh6 in vivo. For example, Msh2 /  mice show microsat-
ellite instability and patients or mice with deficiency in
Msh2 have a strong predisposition to early onset of colon
cancer, whereas Msh6 /  mice do not have microsatellite
instability and mice with Msh6 deficiencies have a later on-
set of malignancies with a predominance of B cell lympho-
mas (45). In addition, Msh6 deficiency changed the posi-
tioning of the junction site in the S  and S 3 switch
regions, suggesting that Msh6 plays a role in the selection
of different S  and S 3 segments for recombination. This
is likely to reflect inherent sequence or higher order DNA
or chromatin structural differences in the switch region
themselves. The shift in sites suggests that Msh6 either
modifies initial lesions that are more common in one sub-
region or is required to resolve or stabilize the double
stranded breaks that occur more frequently in one subre-
gion than another.
In yeast, the Msh2-Msh3 heterodimer plays a role in re-
moving nonhomologous ends from double stranded DNA
breaks (53). In the studies reported here, Msh3 deficiency
did not have any effect on the frequency of CSR, the tar-
geting of mutation or recombination sites or on the size of
microhomologies at the sites of recombination. However,
there were more large inserts in the sites of recombination
in the Msh3 /  mice than in their littermate controls, a
partial phenotype of Msh2 deficiency in the switch junc-
tions. These results suggest that Msh3 is probably not
needed to generate DNA breaks or to resolve the breaks in
CSR. However, the Msh2-Msh3 heterodimer could play a
similar role to that reported in yeast (53) in the processing
of the double stranded breaks in CSR or Msh2 can func-
tion independently of Msh3 during the processing of DNA
break ends.
We compared the characteristics of mutations in the re-
combined S  and S 3 switch regions from Msh6- and
Msh3-deficient mice and their littermate controls. We ana-
lyzed  1,000 base changes from various Msh6 genotypes
and 400 base changes from Msh3 mice. All of the geno-
types had many more mutations in S  than in S 3, consis-
tent with the findings reported by others (32, 36, 54). Be-
cause there were more mutations in S  than in S  switch
regions from cells that have been stimulated but have not
undergone switch recombination, it has been suggested
that AID-dependent mutations in the donor S  initiate the
process of CSR (32). There was no change in the fre-
quency of mutations in either the donor S  or recipient
S 3 switch regions in the Msh6 /  mice compared with
their Msh6 /  littermates. This lack of effect on the fre-
quency of mutations in the switch regions has also been
observed for Msh2-deficient mice and suggests that even
though MMR facilitates efficient CSR, it is not required
for AID-dependent mutations in the switch region (32).
There was a statistically significant lower frequency of mu-
tation in the S  region and S 3 region in Msh6 /  mice
than in Msh6 /  or Msh6 /  mice. In addition, Msh6 / Li et al. 57
mice showed an increased frequency of RGYW hotspot
mutation targeting compared with Msh6 /  mice. It is pos-
sible that haplo insufficiency of Msh6 affects the competi-
tion between MMR and other DNA repair pathways for
the AID-generated mismatches, changes the balance be-
tween BER and MMR and outcome of the repair of G-U
mismatches, and therefore, influences the outcome of the
mutation frequency in recombined switch sequences.
We compared the characteristics of mutations in CSR
and SHM from Msh6-deficient mice and their littermate
controls. In Msh6 /  mice, there was a slight increase of
G/C mutations in the switch regions and a much higher
increase of transition mutations at G/C and in hotspots in
the recombined S  and S 3 regions. When compared with
the changes in the V region (JH2-JH4), the increase in tar-
geting of G/C bases was more dramatic in the V regions,
but targeting of transition mutation at G/C and hotspots
was more dramatic in switch regions. These results suggest
that, in CSR and SHM, Msh6 plays an overlapping and
distinct role. Interestingly, the mutation spectra in the
switch regions from Msh6 /  mice are somewhat similar to
those observed in SHM from Ung /  mice (15), suggesting
that Msh6 and uracil DNA glycosylase are more closely
connected in CSR than in SHM.
We had observed previously that a deficiency in Msh3
did not affect the frequency or characteristics of the AID-
dependent mutations in the V region (21). When we ana-
lyzed many more base changes in V regions of Msh3 / 
mice and added them to the mutations we had examined
previously (21), we noticed that there was a slight increase
in the percentage of mutations at A/T bases. This is the op-
posite of what was seen in Msh2- and Msh6-deficient mice
and could be due to the competition between Msh6 and
Msh3 for Msh2, i.e., loss of Msh3 increases the chance for
the formation of Msh2-Msh6 complex, which ultimately
increases the percentage of A/T mutations. Interestingly,
deficiency in ATM also results in an increase in the percent
of A/T mutations in CSR (55). Error-prone polymerases
may also participate in the mutational process in both the V
and switch regions (1), and a deficiency in polymerase  
results in fewer mutations at A/T in the V region and in
the switch regions (16, 17, 56). Although pol iota has also
been implicated in V region mutation in BL2 cells (57), this
does not seem to be true in mice (32, 58). Together, all of
these findings suggest that the competitive interactions of
many enzymes determine the nature of the mutations that
trigger CSR and the ultimate structure of the recombina-
tion sites.
In conclusion, we have shown that efficient CSR re-
quires Msh6 but not Msh3, that Msh3 /  mice and Msh6 / 
mice exhibit different switch junctions from those of
Msh2 /  mice, and that similar but different mutation
spectra were observed between switch region and V region
mutations from Msh6 /  mice and Msh3 /  mice. Our re-
sults support the idea that Msh2 and Msh6 function to-
gether at the initial step of generating breaks, Msh2 then
functions together with Msh3 and/or Msh2 functions inde-
pendently in the processing of DNA break ends, whereas
Msh6 is not involved in this process, and Msh6 may then
function in the resolution of DNA breaks. Therefore, we
favor the idea that the MutS homologues, Msh2, Msh3,
and Msh6 have overlapping and distinct roles in the process
of SHM and CSR.
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